Slezak Paul, Heher Philipp, Monforte Xavier, Keibl Claudia, Redl Heinz, Spazierer Daniel, Gulle Heinz
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology , Vienna , Austria.
Baxter Medical Products GmbH , Vienna , Austria.
J Invest Surg. 2019 Nov;32(7):646-653. doi: 10.1080/08941939.2018.1447619. Epub 2018 Mar 21.
: Topical hemostatic agents are an important means of controlling or preventing bleeding. This study was performed to compare gelatin-thrombin matrix with smooth particles (SmGM) versus gelatin-thrombin matrix with stellate particles (StGM) in a porcine kidney bleeding model. : In male pigs, reproducible lesions (diameter and depth ∼10 mm) were created in the renal cortex. Each lesion was treated topically using either SmGM or StGM. Blood loss was quantified before and 2, 5 and 10 minutes after treatment. Dry mass, ultrastructural and histologic analyses were also performed. : Thirty-two lesions were treated with SmGM and 32 with StGM; median initial bleeding rates were 27.6 and 29.1 mL/min, respectively. Two minutes post-application, SmGM was associated with significantly less bleeding than StGM (0.574 vs 0.920 mL/min; < .0001). This difference stemmed principally from lesions with initial blood loss >29 mL/min, where bleeding rates at 2 minutes were ∼3-fold higher with StGM (1.636 vs 0.567 mL/min; ≥ 0.040). Dry mass per unit volume of hemostatic agent was significantly higher with SmGM versus StGM. SmGM formed discrete, smooth particles, while StGM particles were stellate and tended to coalesce. Histologic analysis showed more solid mass, larger particles and less intervening space with SmGM versus StGM. : In a severe, high-volume bleeding model, residual bleeding at 2 minutes was significantly lower with SmGM versus StGM, and SmGM showed greater consistency across bleeding intensities. These findings may be attributable to dry mass per unit volume and/or ultrastructural differences between the two agents.
局部止血剂是控制或预防出血的重要手段。本研究旨在比较具有光滑颗粒的明胶-凝血酶基质(SmGM)与具有星状颗粒的明胶-凝血酶基质(StGM)在猪肾出血模型中的效果。
在雄性猪的肾皮质中制造可重复的损伤(直径和深度约10毫米)。每个损伤部位局部使用SmGM或StGM进行治疗。在治疗前以及治疗后2、5和10分钟对失血量进行量化。还进行了干质量、超微结构和组织学分析。
32个损伤部位用SmGM治疗,32个用StGM治疗;初始出血率中位数分别为27.6和29.1毫升/分钟。应用后两分钟,SmGM导致的出血明显少于StGM(0.574对0.920毫升/分钟;P<0.0001)。这种差异主要源于初始失血量>29毫升/分钟的损伤部位,在这些部位,StGM在两分钟时的出血率约为SmGM的3倍(1.636对0.567毫升/分钟;P≥0.040)。SmGM每单位体积止血剂的干质量显著高于StGM。SmGM形成离散的光滑颗粒,而StGM颗粒呈星状且易于聚集。组织学分析显示,与StGM相比,SmGM有更多的固体物质、更大的颗粒和更少的间隙空间。
在严重的、大量出血模型中,SmGM在两分钟时的残余出血量明显低于StGM,并且SmGM在不同出血强度下表现出更大的一致性。这些发现可能归因于两种制剂每单位体积的干质量和/或超微结构差异。